ym 872 has been researched along with lubeluzole in 1 studies
| Studies (ym 872) | Trials (ym 872) | Recent Studies (post-2010) (ym 872) | Studies (lubeluzole) | Trials (lubeluzole) | Recent Studies (post-2010) (lubeluzole) |
|---|---|---|---|---|---|
| 41 | 0 | 5 | 76 | 14 | 10 |
| Protein | Taxonomy | ym 872 (IC50) | lubeluzole (IC50) |
|---|---|---|---|
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | 2.939 | |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | 1.5995 | |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | 2.939 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sareen, D | 1 |
1 review(s) available for ym 872 and lubeluzole
| Article | Year |
|---|---|
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |